Insights

Innovative Product Portfolio Levolta Pharmaceuticals leverages a strong pipeline of novel formulated compounds targeting high-demand therapeutic areas such as rheumatology, CNS, oncology, and immunology, offering potential for expanding into markets with unmet medical needs.

Strategic Partnerships Recent licensing agreement with Tabuk Pharmaceuticals in the Middle East signals an openness to strategic collaborations, opening pathways for international distribution and market expansion.

Market Disruptor Potential With VOLT01 showing promising safety and efficacy in osteoarthritis, the company has the opportunity to become a first-in-class Disease-Modifying Drug, which can significantly impact sales within the osteoarthritis treatment space.

Growth through Acquisitions Levolta’s portfolio growth via acquisitions of IMC Biotechnology and Renascense Pharmaceuticals indicates an active strategy to diversify and expand their product offerings, creating multiple sales avenues across therapeutic sectors.

Market Entry Potential Collaborations and licensing deals with larger pharmaceutical entities such as Astra Industrial Group demonstrate successful market entry strategies that sales teams can target for partnership opportunities or distribution channels.

Similar companies to Levolta Pharmaceuticals, Inc.

Levolta Pharmaceuticals, Inc. Tech Stack

Levolta Pharmaceuticals, Inc. uses 8 technology products and services including WordPress Super Cache, Cloudflare CDN, Cloudflare, and more. Explore Levolta Pharmaceuticals, Inc.'s tech stack below.

  • WordPress Super Cache
    Caching
  • Cloudflare CDN
    Content Delivery Network
  • Cloudflare
    Content Management System
  • MySQL
    Database
  • oEmbed
    Dev Tools
  • Twemoji
    Font Scripts
  • jQuery
    Javascript Libraries
  • Google Maps
    Maps

Levolta Pharmaceuticals, Inc.'s Email Address Formats

Levolta Pharmaceuticals, Inc. uses at least 1 format(s):
Levolta Pharmaceuticals, Inc. Email FormatsExamplePercentage
FLast@levoltapharma.comJDoe@levoltapharma.com
50%
FLast@levoltapharma.comJDoe@levoltapharma.com
50%

Frequently Asked Questions

Where is Levolta Pharmaceuticals, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Levolta Pharmaceuticals, Inc.'s main headquarters is located at 116 Research Drive Bethlehem, Pennsylvania 18015 United States. The company has employees across 1 continents, including North America.

What is Levolta Pharmaceuticals, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Levolta Pharmaceuticals, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Levolta Pharmaceuticals, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Levolta Pharmaceuticals, Inc.'s official website is levoltapharma.com and has social profiles on LinkedIn.

What is Levolta Pharmaceuticals, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Levolta Pharmaceuticals, Inc.'s SIC code is 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Levolta Pharmaceuticals, Inc. have currently?

Minus sign iconPlus sign icon
As of March 2026, Levolta Pharmaceuticals, Inc. has approximately 3 employees across 1 continents, including North America. Key team members include Chief Executive Officer: R. B.Chief Medical Officer: K. D.. Explore Levolta Pharmaceuticals, Inc.'s employee directory with LeadIQ.

What industry does Levolta Pharmaceuticals, Inc. belong to?

Minus sign iconPlus sign icon
Levolta Pharmaceuticals, Inc. operates in the Pharmaceutical Manufacturing industry.

What technology does Levolta Pharmaceuticals, Inc. use?

Minus sign iconPlus sign icon
Levolta Pharmaceuticals, Inc.'s tech stack includes WordPress Super CacheCloudflare CDNCloudflareMySQLoEmbedTwemojijQueryGoogle Maps.

What is Levolta Pharmaceuticals, Inc.'s email format?

Minus sign iconPlus sign icon
Levolta Pharmaceuticals, Inc.'s email format typically follows the pattern of FLast@levoltapharma.com. Find more Levolta Pharmaceuticals, Inc. email formats with LeadIQ.

When was Levolta Pharmaceuticals, Inc. founded?

Minus sign iconPlus sign icon
Levolta Pharmaceuticals, Inc. was founded in 2013.

Levolta Pharmaceuticals, Inc.

Pharmaceutical ManufacturingPennsylvania, United States2-10 Employees

Based in Bethlehem, Pa., Levolta Pharmaceuticals features a portfolio of early-stage small molecules and late-stage novel formulated compounds for rheumatology, the central nervous system, oncology and immunology, which the company obtained through the acquisitions of IMC Biotechnology and Renascense Pharmaceuticals. The portfolio is designed to overcome current treatment barriers through an enhanced therapeutic index that drives customer value

It's lead product, VOLT01, is a reformulated Zoledronic Acid (ZA) that has demonstrated significantly better safety and efficacy in controlling knee osteoarthritis compared to ZA alone, with the added benefit of no post dosing symptoms. VOLT01 has the potential to be the first Disease-Modifying Drug (DMARD) for osteoarthritis.

For more information, please call (848) 702-0682 or visit www.levoltapharma.com.

Section iconCompany Overview

Headquarters
116 Research Drive Bethlehem, Pennsylvania 18015 United States
Phone number
SIC Code
5122 - Drugs, Drug Proprietaries, and Druggists' Sundries
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2013
Employees
2-10

Section iconFunding & Financials

  • $1M$10M

    Levolta Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Levolta Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.